FDA seeks with­draw­al of heart­burn drugs due to new car­cino­gen con­cerns

The FDA on Wednes­day re­quest­ed that all man­u­fac­tur­ers of drugs con­tain­ing ran­i­ti­dine (com­mon­ly known as Zan­tac and used for heart­burn) re­move all pre­scrip­tion and over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER